From COPD to COVID-19: How Hydrogen Therapy Targets Lung Inflammation

Research studies report a plethora of beneficial effects of molecular hydrogen therapy on respiratory health.

“H₂ is emerging as a novel and well-tolerated therapeutic option with multifaceted antioxidant, anti-inflammatory, anti-apoptotic, and immunomodulatory properties, demonstrating protective effects across a wide spectrum of respiratory diseases including COPD, asthma, lung injury, PF, PH, lung cancer, and COVID-19. Preclinical studies consistently reveal its capacity to modulate oxidative stress, inflammation, mitochondrial dynamics, and immune responses, while early clinical findings and case reports suggest promising translational potential” (Chuang, 2026).

The wide ranging effects of molecular hydrogen therapy make it suitable for a variety of conditions. Its ability to lower inflammation and support immune function make it a versatile therapy.

“Molecular hydrogen has garnered increased attention as a relatively simple, cost-effective, and safe treatment option for acute and chronic respiratory diseases. Its multifaceted activity involving anti-inflammatory, antioxidant, and antiapoptotic mechanisms facilitates a more holistic approach to the treatment, addressing multiple facets of the disease rather than a single symptom or pathway” (Qian, et al., 2022)

Molecular hydrogen has a generalized effect that supports the whole body, not just one specific system. This makes the therapy a safe option for most clients.

“An increasing number of studies have revealed that hydrogen may protect the lungs from diverse diseases, including acute lung injury, chronic obstructive pulmonary disease, asthma, lung cancer, pulmonary arterial hypertension, and pulmonary fibrosis” (Fu and Zhang, 2022).

The preventative effects of molecular hydrogen therapy can help you avoid succumbing to respiratory diseases that run in your family or to conditions to which you are susceptible due to environmental factors.

Schedule a 30 minute molecular hydrogen therapy session at Renewed Hope Nutrition to begin your healing journey.

References

Chuang, Ya-Ting, et al. “Molecular Hydrogen Therapy in Respiratory Diseases: Mechanisms, Evidence, and Technical Considerations.” All Life, vol. 19, no. 1, 2026, article 2643533. Taylor & Francis, https://doi.org/10.1080/26895293.2026.2643533.

Fu, Zhiling, and Jin Zhang. “Molecular Hydrogen Is a Promising Therapeutic Agent for Pulmonary Disease.” Journal of Zhejiang University-SCIENCE B, vol. 23, no. 2, 2022, pp. 102–122. https://doi.org/10.1631/jzus.B2100420. 

Qian, Linlin, et al. “A Sequence Variation in GmBADH2 Enhances Soybean Aroma and Is a Functional Marker for Improving Soybean Flavor.” International Journal of Molecular Sciences, vol. 23, no. 8, 2022, article 4116. MDPI, https://doi.org/10.3390/ijms23084116.